Recently, the demand for hybrid PET/MRI imaging techniques has increased significantly, which has sparked the investigation into new ways to simultaneously track multiple molecular targets and improve the localization and expression of biochemical markers. Multimodal imaging probes have recently emerged as powerful tools for improving the detection sensitivity and accuracy—both important factors in disease diagnosis and treatment; however, only a limited number of bimodal probes have been investigated in preclinical models. Herein, we briefly describe the strengths and limitations of PET and MRI modalities and highlight the need for the development of multimodal molecularly-targeted agents. We have tried to thoroughly summarize data on bimodal probes available on PubMed. Emphasis was placed on their design, safety profiles, pharmacokinetics, and clearance properties. The challenges in PET/MR probe development using a number of illustrative examples are also discussed, along with future research directions for these novel conjugates.
Many siderophores incorporate as bidentate chelating subunits linear and more seldomly cyclic hydroxamate groups. In this work, a comparative study of the uranyl binding properties in aqueous solution of two monohydroxamic acids, the prototypical linear N-methylacetohydroxamic acid (NMAH) and the cyclic analog 1-hydroxypiperidine-2-one (PIPOH), has been carried out. The complex [UO2(PIPO)2(H2O)] crystallized from slightly acidic water solutions (pH < 5), and its molecular structure was determined by X-ray diffraction. The uranyl speciation in the presence of both ligands has been thoroughly investigated in a 0.1 M KNO3 medium at 298.2 K by the combined use of four complementary techniques, i.e., potentiometry, spectrophotometry, Raman spectroscopy, and affinity capillary electrophoresis. Preorganization of the hydroxamate ligand for chelation by incorporation into a cyclic structure, as in PIPO−, results in an increase of nearly one order of magnitude in the formation constants of the uranyl complexes of 1 : 1 and 1 : 2 metal/ligand stoichiometries.
Compound [Fe(H2-4OH-L6)]Cl was used for preparation of four new ion-pair complexes with general formula: [Fe(H2-4OH-L6)][M(L3)2]·H2O (M = CoIII (3a), CrIII (3b) and FeIII (3c)) and [Fe(H2-4OH-L6)][Ag(CN)2] (3d), where H4-4OH-L6 = N,N′-bis[2,4-dihydroxy-(benzylideneamino)ethyl]ethane-1,2-diamine and H2L3 = 2-{(E)-[(2-hydroxyphenyl)imino]methyl}phenol. Furthermore, two [Fe(H-4OH-L6)] complexes (1a and 1b) with monodeprotonated hexadentate ligands were prepared. The crystal structures were determined by single-crystal X-ray measurements for all the above-mentioned complexes excluding 3c. Its isostructurality with 3a–b was confirmed by powder X-ray diffraction. The magnetic properties were investigated by static magnetic measurements and they are dominated by the high spin ground state of the complex cations and anions and at a smaller scale by the intermolecular interactions present among the molecules. The susceptibility and magnetization data were fitted simultaneously using the model for monomeric complexes including the zero-field splitting and the molecular field correction and these studies were supported also by CASSCF/NEVPT2 and BS-DFT calculations.
29 September 2017 in European Journal of Organic Chemistry
An efficient semisynthesis of silylated l‐amino acids by reaction of silylated benzaldehydes with a phosphonium l‐amino acid used as a Wittig reagent is described. The efficiency of the silylated l‐amino acids in peptide synthesis was investigated by coupling both the carboxylic acid and the amino moiety with l‐alanine and phenylalanine derivatives, respectively. The silylated derivatives were treated with KF or tetrabutylammonium fluoride to give the corresponding fluorosilyl derivatives without racemization. The hydrolysis of the fluorosilylated derivatives in phosphate buffer at pH 7.2 was checked. Finally, the 18F‐labelling of di‐tert‐butylsilylated saturated and unsaturated dipeptides was achieved in hot DMSO with a mixture of K[18F]/cryptand (K2.2.2) and acetic acid. The 18F‐labelled dipeptides were obtained with radiochemical yields and molar activities of up to 31 % and 410 GBq/µmol, respectively. Consequently, this semisynthesis involving a Wittig reaction offers a new and efficient route for the design and 18F‐labelling of Si‐based amino acids and peptide derivatives, which may find applications in PET imaging.
1 August 2018 in Journal of Radioanalytical and Nuclear Chemistry
Six‐ and seven‐membered cyclic hydroxamic acids are found as terminal binding units in different families of siderophores, including exochelins and mycobactins. The simplest models of these preorganized chelating ligands were known, but their coordination chemistry with Fe3+, the target metal ion of siderophores, had never been reported. Four complexes were synthesized and studied: two Fe3+ complexes, one with the six‐membered ring hydroxamate PIPO− and one with the seven‐membered ring hydroxamate AZEPO−, and the two corresponding Ga3+ complexes. X‐ray diffraction studies showed that the interligand repulsion energies were better minimized in the case of the AZEPO− complexes whatever the metal cation considered, and that the Fe−O bond distances were shorter in [Fe(AZEPO)3] by comparison with [Fe(PIPO)3].